To study and compare the effect of Raladi Lepa and Shrungaberadi Lepa in the managment of Dadru Kushta with special reference to Tinea (Corporis And Cruris)
Phase 2
- Conditions
- Health Condition 1: L309- Dermatitis, unspecified
- Registration Number
- CTRI/2022/02/040479
- Lead Sponsor
- Dr Sachin Pawar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subjects of Dadru with cardinal signs and symptoms Kandu (Itching),Raga(Redness), and Pidaka (Eruption) will be selected for this study.
2.Subjects between the age group of 18 to 70 years both inclusive will be selected for
this study.
3.Both Male and Female (non-pregnant, non-lactating) gender Subjects are included in
the study
4.Written consent showing willingness to participate in the study.
Exclusion Criteria
1.Subjects of Severe/Chronic hepatic or renal disease .
2.Subjects with known Chronic Infectious Disease, such as active Tuberculosis,
Hepatitis B or C, or HIV.
3.Chronicity more than 2 years.
4.Pregnant women and lactating mothers.
5.Age group below 18 and above 70 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Controlled study of Raladi lepa in Dadru kushta <br/ ><br>w.s.r. to tinea corporis and cruris <br/ ><br> <br/ ><br>Timepoint: 0 to 21 days <br/ ><br>
- Secondary Outcome Measures
Name Time Method To study the efficacy of Raladi lepa in <br/ ><br>management of Dadru kushta <br/ ><br>To study the effects of Shrungaberadi lepa <br/ ><br>To compare the results of both groupsTimepoint: 0 to 21 days